July 2, 2024
Tattoo Numbing Cream Market

Tattoo Numbing Cream Market Set to Witness a Massive Growth during 2024 to 2031 Trends in Popularity of Tattoos.

Tattoo numbing cream are topical anesthetics applied on skin before tattooing or other painful procedures to help reduce pain sensation. They contain active numbing ingredients like benzocaine, lidocaine or tetracaine which work by temporarily blocking the transmission of pain signals. Tattoos have become quite popular among people of all ages as a form of self-expression. Tattoo numbing creams offer a convenient painless way to get inked. Their various benefits include quicker healing, less trauma to skin, and ability to sit comfortably through long tattoo sessions.

The global tattoo numbing cream market is estimated to be valued at US$ 2,014.8 million in 2024 and is expected to exhibit a CAGR of 7.4% over the forecast period 2024 to 2031.

Key Takeaways

Key players: Key players operating in the tattoo numbing cream market are OEK FACTORY, Zensa Skin Care, Salvepharma, Aspen Pharmacare Australia Pty Ltd, Hera Beauty Ltd, Tattoo Numbing Cream Co., Dr. Numb, Toochi Tattoo, Centura Pharmaceuticals, Bulletproof industries NZ, Painless Topical Anaesthetic Cream, Beardo India, Tattoo Fix care, Cellular cosmetics, Pure Source, Lady Burd, My Skincare Manufacturer. These players are focusing on expanding their product portfolios and global footprint through mergers and acquisitions.

Growing demand: There is a growing demand for Tattoo Numbing Cream Market Size among millennials and generation z consumers who want fashionable body tattoos without pain. The demand is further expected to increase with rising social acceptance of tattoos.

Global expansion:
Leading players are expanding their production and distribution networks globally especially in developing countries to tap the vast untapped markets. New players are also entering the market with customized products catering to specific regional demands.

Market key trends

One of the key trends gaining momentum in the tattoo numbing cream market is the launch of spray and roll-on formulations. Products like Dr. Numb Spray and Orabase numbing spray are fast acting and easy to apply without rubbing on skin. They provide quick pain relief within 5 minutes of application. Manufacturers are also coming up with natural and herbal formulations containing numbing plant extracts to cater to the rising demand for milder products with fewer side effects. Such product innovations are expected to drive the future growth momentum of the tattoo numbing cream market.”

Porter’s Analysis

Threat of new entrants: Low as the market requires significant capital investments and established distribution channels.

Bargaining power of buyers:
High as the market has numerous established players providing variety of options to buyers.

Bargaining power of suppliers: Moderate as suppliers have varying production capacities and capabilities.

Threat of new substitutes: Low as tattoo numbing creams have few close substitutes and target a niche segment of tattoo and skin care.

Competitive rivalry: Fierce as the market has numerous global and local players competing on basis of quality, price and innovation.

Geographical Regions

North America remains the largest market for tattoo numbing creams in terms of value owing to high prevalence of tattoo culture and rising number of tattoo parlors in countries like US and Canada. Europe is also a major regional market led by countries like Germany, UK and France with growing acceptance of tattoos.

Asia Pacific region is expected to witness fastest growth during forecast period led by China, India and Japan. Rising disposable incomes, exposure to western culture and increasing number of millennials opting for tattoos are driving the market growth in the region. Other emerging regions such as Latin America and Middle East & Africa also offer promising growth opportunities for players.

*Note:
1. Source: Coherent Market Insights, Public Source, Desk Research
2. We have leveraged AI tools to mine information and compile it.